Do Interference-Based Cut-Points Differentiate Mild, Moderate, and Severe Levels of 16 Cancer-Related Symptoms Over Time?

Journal of Pain and Symptom Management

Volumn 37, Issue 2, 2009, Pages 220-232

  Jeon, Sangchoon ^a   Given, Charles W ^a   Sikorskii, Alla ^a   Given, Barbara ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Anchor based responses; levels of severity; measurement of symptom severity change

Indexed keywords

ADULT; AGED; ALOPECIA; ANOREXIA; ANXIETY; ARTICLE; BREAST CANCER; BRIEF PAIN INVENTORY; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; COLON CANCER; CONSTIPATION; COUGHING; DAILY LIFE ACTIVITY; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MUSCLE WEAKNESS; NAUSEA; NEOPLASM; PERIPHERAL NEUROPATHY; RATING SCALE; SLEEP DISORDER; SYMPTOM; VOMITING; XEROSTOMIA;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 59649120904     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2008.01.010     Document Type: Article

References (25)

1. Cleeland C.S. Measurement of pain by subjective report. In: Chapman C.R., and Loeser J.D. (Eds). Issues in pain measurement. Advances in pain research and therapy vol. 12 (1989), Raven Press, New York 391-403
2. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients. Cancer 85 5 (1999) 1186-1196
3. Cleeland C., Mendoza T., Wang X., et al. Assessing symptom distress in cancer patients. Cancer 89 (2000) 1634-1646
4. Serlin R.C., Mendoza T.R., Nakamura Y., et al. When is cancer pain mild, moderate, or severe? Grading pain severity by its interference with function. Pain 61 (1995) 277-284
5. Palos G.R., Mendoza T.R., Mobley G.M., et al. Asking the community about cut-points used to describe mild, moderate, and severe pain. J Pain 7 1 (2006) 49-56
6. Paul S.M., Zelman D.C., Smith M., et al. Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 113 (2005) 37-44
7. Zelman D.C., Dukes E., Brandenburg N., Bostrom A., and Gore M. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain 115 1-2 (2005) 29-36
8. Given B., Given C.W., Sikorskii A., et al. Establishing mild, moderate and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference based severity cut-points?. J Pain Symptom Manage 35 2 (2008) 126-135
9. Schwartz C., Bode R., Repucci N., Becker J., and Sprangers A. The clinical significance of adaptation to changing health: a meta-analysis of response shifts. Qual Life Res 15 (2006) 1533-1550
10. Farrar J.T., Portenoy R.K., Berlin J.A., et al. Defining the clinically important differences in pain outcome measures. Pain 88 (2000) 287-294
11. Dionne R.A., Bartoshuk L., Mogil J., et al. Individual responder analyses for pain: does one pain scale fit all?. Trends Pharmacol Sci 26 3 (2005) 125-130
12. Farrar J.T., Young Jr. J.P., LaMoreaux L., et al. Clinical importance of chances in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
13. Miaskowski C., Dodd M., West C., et al. The use of responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain 129 (2007) 55-63
14. Sikorskii A., Given C., and Given B. Symptom management for cancer patients: a trial comparing two multimodal interventions. J Pain Symptom Manage 34 3 (2007) 253-264
15. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Available from (2006). http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf Accessed September 28, 2007
16. Barsky A.J., and Ahern D. Cognitive behavior therapy for hypochondriasis. JAMA 291 (2004) 1464-1470
17. McGinn L., and Sanderson W. What allows cognitive behavioral therapy to be brief: overview, efficacy and crucial factors facilitating brief treatment. Psychol Sci Pract 8 (2001) 23-73
18. Dobson K., and Dozios D. Historical and philosophical bases of cognitive behavioral therapy. In: Dobson K.S. (Ed). Handbook of cognitive behavioral therapies (2001), Guilford Press, New York 3-39
19. Miaskowski C., and Lee K. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 17 5 (1999) 320-332
20. Anderson K., Getto C., Mendoza T., et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage 25 4 (2003) 307-318
21. Berger A. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25 1 (1998) 51-61
22. McCullagh P., and Nelder J. Generalized linear models (1989), Chapman and Hall, London
23. Searle S.R., Speed F., and Miliken G.A. Population marginal means in the linear model: an alternative to least squares means. Am Stat 34 (1980) 216-221
24. SAS Institute Inc. SAS software, version 9 of the SAS system for Windows (2002-2003), SAS Institute Inc., Cary, NC
25. Basch E., Iasonos A., and Bartz A. Long-term toxicity monitoring via electronic patient reported outcomes in patients receiving chemotherapy. J Clin Oncol 25 (2007) 5374-5380